Effect of Rasagiline in Patients With Parkinson's Disease
- Study Title
- ParFemale, Maleel-Group Study to Assess the Effect of Rasagiline on Cognition in Patients With Parkinson's Disease
- Teva Identifier
- TVP-1012/PM106
- ClinicalTrials.gov Identifier
- NCT01723228
- Study Status
- Completed
- Trial Condition(s)
- Parkinson's Disease
- Interventions
- Drug: Rasagiline | Drug: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 45 Years to 80 Years
- Trial Duration
- 11/01/2012 - 01/01/2015
- Phase
- Phase 4